Standard BioTools Inc.
LAB
$0.67
$0.023.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 84.91M | 78.21M | -74.90M | -128.25M | -120.50M |
| Total Depreciation and Amortization | 9.56M | 10.30M | 10.98M | 18.18M | 16.14M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -135.68M | -133.19M | 34.55M | 28.89M | 28.68M |
| Change in Net Operating Assets | -39.09M | -45.97M | -44.98M | -6.03M | -17.19M |
| Cash from Operations | -80.30M | -90.66M | -74.34M | -87.21M | -92.88M |
| Capital Expenditure | -2.28M | -3.82M | -8.30M | -11.21M | -12.58M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -1.39M | -1.39M |
| Divestitures | 388.21M | 363.22M | -- | -- | -- |
| Other Investing Activities | -195.16M | -155.53M | 35.71M | 73.77M | 50.94M |
| Cash from Investing | 190.78M | 203.87M | 27.41M | 61.18M | 36.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -55.00M | -55.00M |
| Issuance of Common Stock | 944.00K | 1.13M | 1.05M | 833.00K | 901.00K |
| Repurchase of Common Stock | -614.00K | -556.00K | -484.00K | -403.00K | -361.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 330.00K | 576.00K | 570.00K | -54.57M | -54.46M |
| Foreign Exchange rate Adjustments | 106.00K | 600.00K | 842.00K | 675.00K | 470.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.91M | 114.39M | -45.52M | -79.93M | -109.90M |